Nestmedic has acquired 8 million PLN from the capital increasing through issuing of new shares and planning debut on NewConnect17-03-2017
Nestmedic – the author of a world scale innovative solution Pregnabit – has finished share issuing and acquired 8 million polish zloty with plans of NewConnect debut in August 2017, as the company announced.
“Our aim was to acquire 4 million PLN which after setting the issue price would constitute 6% of the company capital. Taking into account that there was so much interest in shares, we have decided to increase number of shares. Thanks to that we are not planning another issuing which previously had been set at the end of the year” – said President Patrycja Wizińska-Socha.
Share subscriptions have started in Mid-January 2017. The capital from issuing shares will be spend on new product sales development as well as on additional workings on a second-generation Pregnabit device. Now, the KTG Pregnabit using for remote check-ups and platform aimed for analyzing KTG results is still in beta-testing phase, as mentioned in announcement.
“Our sales process was also supported with beta-testing program supervised by gynecologists, which was aimed for further improvement of facilities and services in order to prepare for global expansion. The program is based on advanced optimization schemes of products that are newly-introduced by the most innovative enterprises operating in “digital-health” sector – said Agnieszka Skotny.
The Company plans to finish beta-tests till June 2017. Sales strategy of Nestmedic includes also entering on new foreign markets. The Company has obtained CE and ISO 13485 certificates that allow to sale products in the whole European Union. Nestmedic has also just launched the process of certification on the other markets, for example in USA (FDA certificate).